SCHEMBL7744003

SCHEMBL7744003

COc1ccc2nc(C(=O)O)c(OCc3ccccc3)cc2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 2/20 0.57
PDGFRB P09619 1/20 0.52
PDGFRA P16234 1/20 0.52
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
HSP90AA1 P07900 1/20 0.50
HTT P42858 4/20 0.49
MAPT P10636 4/20 0.49
SMN1; SMN2 Q16637 4/20 0.49
KDM4E B2RXH2 3/20 0.47
SCD O00767 1/20 0.47
POLB P06746 1/20 0.47
RECQL P46063 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
SRD5A1 P18405 2/20 0.47
SRD5A2 P31213 2/20 0.47
MRGPRX4 Q96LA9 1/20 0.47
STAT3 P40763 1/20 0.47
MTNR1A P48039 1/20 0.47
MTNR1B P49286 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6566122 0.93 HDAC8 (0.51) HDAC8PDGFRBPDGFRAMEN1KMT2A
SCHEMBL6567304 0.92 HDAC8 (0.56) HDAC8PDGFRBPDGFRAMEN1KMT2A
SCHEMBL8629707 0.88 MCL1 (0.51) HDAC8PDGFRBPDGFRAMEN1KMT2A
SCHEMBL8625477 0.88 MCL1 (0.48) HDAC8PDGFRBPDGFRAMEN1KMT2A
SCHEMBL8629713 0.87 KMT2A (0.53) HDAC8PDGFRBPDGFRAMEN1KMT2A
SCHEMBL8629309 0.87 MEN1 (0.53) HDAC8PDGFRBPDGFRAMEN1KMT2A
SCHEMBL8632085 0.86 HDAC8 (0.50) HDAC8PDGFRBPDGFRAMEN1KMT2A
SCHEMBL6564097 0.86 HDAC8 (0.50) HDAC8PDGFRBPDGFRAMEN1KMT2A
SCHEMBL7746386 0.85 STAT3 (0.52) MEN1KMT2AHSP90AA1HTTSMN1; SMN2
SCHEMBL31220380 0.85 CCR5 (0.47) HDAC8MEN1KMT2AHTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1120157-C Substituted quinoline-2-carboxamides, process for their preparation and their use as pharmaceuticals, and intermediates thereof FIBER GENE CORP (US) 2003-09-03 CN disclosed
US-6329497-B1 ANTITUMOR AGENTS; VIRICIDES AGAINST HUMAN IMMUNODEFICIENCY VIRUS THE SCRIPPS RESEARCH INSTITUTE 2001-12-11 US disclosed
EP-0996458-A4 SANDRAMYCIN ANALOGS SCRIPPS RESEARCH INST (US) 2001-05-02 EP disclosed
CN-1282737-A Intermediate product used for preparing substituted quinoline-2-formamide MOECHST AG (DE) 2001-02-07 CN disclosed
EP-0996458-A1 SANDRAMYCIN ANALOGS The Scripps Research Institute (US) 2000-05-03 EP disclosed
WO-1998043663-A1 SANDRAMYCIN ANALOGS THE SCRIPPS RESEARCH INSTITUTE (US) 1998-10-08 WO disclosed
US-5726305-A Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates HOECHST AKTIENGESELLSCHAFT (DE) 1998-03-10 US disclosed
US-5719164-A Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates HOECHST AKTIENGESELLSCHAFT (DE) 1998-02-17 US disclosed
CN-1154365-A Substituted quinoline-2-carboxamides, process for their preparation and their use as pharmaceuticals, and intermediates thereof HOECHST AG (DE) 1997-07-16 CN disclosed